Epithalon mg to units converter

Epithalon, also spelled Epitalon, is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) with a research history deeply rooted in gerontology and bioregulation. Its origin is tied to the work of Vladimir Khavinson and his colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, who first derived it from epithalamin, a polypeptide preparation extracted from bovine pineal glands. The scientific literature, which originated predominantly in Russian-language journals before appearing more broadly, almost exclusively frames Epithalon in the context of its pineal gland connection. This unique background informs its two primary areas of study: the regulation of telomerase activity and the modulation of circadian rhythms.

The dual identity of Epithalon as both a potential telomerase influencer and a regulator of pineal function sets it apart from other peptides. Research papers often explore its capacity to activate the telomerase enzyme, which is responsible for maintaining the length of telomeres at the ends of chromosomes, a key area of interest in aging research. Concurrently, other studies document its effects on the pineal gland's production of melatonin and the subsequent normalization of the sleep-wake cycle. Both spellings, Epithalon and Epitalon, are used interchangeably in scientific papers and on supplier materials, making it essential to recognize them as referring to the same substance when logging or planning research protocols.

The mechanism of Epithalon is investigated along two distinct but related pathways, both stemming from its origins in the pineal gland. The first area of study centers on its interaction with the telomerase enzyme. In various in-vitro and animal studies, researchers observe that the administration of Epithalon is followed by an increase in telomerase activity and a subsequent elongation of telomeres in certain cell populations, prompting further investigation into its role in cellular lifespan and senescence. These studies seek to document how a peptide derived from a key endocrine gland might exert influence over fundamental genetic maintenance processes.

The second pathway involves its regulatory effects on the neuroendocrine system, specifically the pineal gland's synthesis of melatonin. Epithalon is not a direct melatonin precursor or analog; instead, research literature examines its ability to modulate pinealocyte function, potentially restoring endogenous melatonin production to more youthful patterns and normalizing disrupted circadian rhythms. This proposed mechanism aligns with the pineal gland's established role as the master regulator of the body's internal clock, suggesting that Epithalon's function may be to support the gland's own rhythmic operations rather than to replace its hormonal output directly.

For Epithalon, the most informative data points to log for longitudinal review are the cycle start and end dates. Because research protocols are structured around short, discrete administration periods followed by long planned breaks, a simple list of daily doses is less meaningful than a clear record of these cycles. Documenting the specific date ranges of each 10-to-20-day course makes it possible to analyze the protocol's timing, frequency, and duration on a year-over-year basis. This high-level view is essential for anyone aiming to observe patterns consistent with the published literature.